Aside from regional lymph node status, vessel invasion, and adjuvant chemotherapy, the authors identified high nuclear survivin expression in the primary tumours as an additional independent prognostic factor due to significantly shorter disease-specific survival intervals. The gene discussed is BIRC5; the disease is neoplasm.